pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 2·1 min read
save

Trump administration releases Medicaid work-requirement rules, prompting state compliance challenges

Jun 2, 2026·read at STAT ↗RegulatoryNeutral

The Morning Rounds newsletter highlighted several health‑policy developments, notably new Medicaid work‑requirement rules and fast‑tracked funding for experimental Ebola vaccines.

The Trump administration issued guidance requiring adults who joined Medicaid through the expansion or who are low‑income non‑Medicare enrollees to complete at least 80 hours each month of work, community service, or education-half of which must be education. Exemptions exist for individuals deemed medically frail, though the criteria for medical frailty remain unclear.

States are expected to interpret and implement the rules quickly, while the broader health news includes accelerated funding for Ebola vaccine trials, underscoring ongoing policy actions that could affect healthcare costs and pharmaceutical activity.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “How one state’s medical meal program lowered health care costs”

read at STAT ↗
1,164 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADINGProtara Therapeutics, Inc.Ultragenyx Pharmaceutical Inc.
drugs
Ebola vaccine
topics
Vaccines6Psychiatry & CNS4Vaccine2CardiologyHeart FailureNephrologyOncologyRare DiseaseType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 5h agoEyepoint, Enlivex enact heavy layoffsBioSpace
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Nouscom nabs $135M series D; Estuary channels $93M series AFierce Biotech
  • Sep 11Boycott launched against American Diabetes Association includes journalSTAT